NCT01796028View on ClinicalTrials.gov

Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

May 31, 2018

Conditions
Prostatic Neoplasms
Interventions
DRUG

METFORMIN

DRUG

Placebo

DRUG

TAXOTERE®

Trial Locations (1)

06189

Centre ANTOINE LACASSAGNE, Nice

All Listed Sponsors
lead

Centre Antoine Lacassagne

OTHER

NCT01796028 - Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancer | Biotech Hunter | Biotech Hunter